NCT03188536 · OUTCOME
Percentage of Participants With Health Care Resource Utilization (HU)
Clinical and Sociodemographic Characterization of Multiple Myeloma Participants With Symptomatic Relapse and/or Refractory Disease in Spain (CharisMMa Study) · Source last updated 2020-10-12
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- percentage of participants
- Interval / dispersion
- Not reported
- Time frame
- Day 1
What was measured
Healthcare resources used during medical encounters include intensive care unit (ICU) admissions, hospital admissions, visits to the emergency room, days admitted.
Analysis population: All participants eligible for analyses were included.
Groups in this outcome
Multiple Myeloma (MM) Participants
Adult participants with a diagnosis of MM received at least one previous treatment line (standard care of treatment) and experienced symptomatic relapse and/or refractory disease in the previous 6 months, who were followed-up at the time of the study visit. No intervention was administered in this study.
Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.
Analysis denominator · Participants
| Group | Source count |
|---|
| Multiple Myeloma (MM) Participants | 276 |
|---|
Reported measurements
Admitted at some healthcare service
Values in percentage of participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Multiple Myeloma (MM) Participants | 56.2 | Not reported | Not reported | Not reported | Not reported |
|---|
Admitted to Hospital
Values in percentage of participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Multiple Myeloma (MM) Participants | 59.4 | Not reported | Not reported | Not reported | Not reported |
|---|
Used ambulance to attend to the hospital
Values in percentage of participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Multiple Myeloma (MM) Participants | 7.0 | Not reported | Not reported | Not reported | Not reported |
|---|
Used their own transport
Values in percentage of participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Multiple Myeloma (MM) Participants | 67.8 | Not reported | Not reported | Not reported | Not reported |
|---|
Consultation with the primary care physician
Values in percentage of participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Multiple Myeloma (MM) Participants | 21.7 | Not reported | Not reported | Not reported | Not reported |
|---|
Consultation with the oncologist
Values in percentage of participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Multiple Myeloma (MM) Participants | 2.5 | Not reported | Not reported | Not reported | Not reported |
|---|
Consultation with the psychologist
Values in percentage of participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Multiple Myeloma (MM) Participants | 3.6 | Not reported | Not reported | Not reported | Not reported |
|---|
Attended psychologist
Values in percentage of participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Multiple Myeloma (MM) Participants | 60 | Not reported | Not reported | Not reported | Not reported |
|---|
Attended hematologist
Values in percentage of participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Multiple Myeloma (MM) Participants | 89.1 | Not reported | Not reported | Not reported | Not reported |
|---|
Required some test
Values in percentage of participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Multiple Myeloma (MM) Participants | 82.2 | Not reported | Not reported | Not reported | Not reported |
|---|
Had undergone X-ray test
Values in percentage of participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Multiple Myeloma (MM) Participants | 43.2 | Not reported | Not reported | Not reported | Not reported |
|---|
Complete source fields
- classes
- title
- Admitted at some healthcare service
- title
- Admitted to Hospital
- title
- Used ambulance to attend to the hospital
- title
- Used their own transport
- title
- Consultation with the primary care physician
- title
- Consultation with the oncologist
- title
- Consultation with the psychologist
- title
- Attended psychologist
- title
- Attended hematologist
- title
- Required some test
- title
- Had undergone X-ray test
- description
- Healthcare resources used during medical encounters include intensive care unit (ICU) admissions, hospital admissions, visits to the emergency room, days admitted.
- groups
- description
- Adult participants with a diagnosis of MM received at least one previous treatment line (standard care of treatment) and experienced symptomatic relapse and/or refractory disease in the previous 6 months, who were followed-up at the time of the study visit. No intervention was administered in this study.
- id
- OG000
- title
- Multiple Myeloma (MM) Participants
- param Type
- NUMBER
- population Description
- All participants eligible for analyses were included.
- reporting Status
- POSTED
- time Frame
- Day 1
- title
- Percentage of Participants With Health Care Resource Utilization (HU)
- type
- SECONDARY
- unit Of Measure
- percentage of participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice